Cancer Treatment Modalities: Biotherapy (Immunotherapy and Targeted Therapy) Flashcards
Biotherapy =
Any form of treatment that uses the body’s natural abilities, or made from living organisms/lab to fight invading organisms, disease processes, or effects of treatment
Difference between biotherapy and chemotherapy =
Focus on body’s biologic role in tumor development or its response to a tumor or treatment (indirectly acts on immune system) vs. cytotoxic chemo affects all cells not just tumor cells
Targeted therapy =
Treatment that uses drugs or other substances to identify and attack specific cancer cells with less harm to normal cells
- some block action of certain enzymes, proteins, molecules involved in growth and spread of cancer cells
Immunotherapy =
Uses substances to stimulate or suppress immune system to help body fight cancer, infection, diseases
Growth signal inhibitors, Angiogenesis inhibitors, Apoptosis inducing drugs are all examples of?
Targeted therapy
Types of biotherapy (2)
Immunotherapy
Targeted therapy
Immunotherapy works by? (3)
1) Boost immune system
2) Enable immune system to
3) Recognize and fight tumor
Stop or slow cancer growth
Classes of immunotherapy (5)
1) Monoclonal antibodies
2) Vaccines
3) Cytokines
4) Adoptive cell therapy
5) Checkpoint inhibitors
Cytokines =
Hormone-like proteins with low molecular weight that are secreted by various cell types, which regulate intensity and duration of immune response and mediate cell to cell communication
Classes of Cytokines (3)
1) CSFs, HGFs, GCSFs
2) Interferons (IFN alpha 2a, beta 1a, beta 1b, gamma 1b)
3) Interleukins (ILs)
Mechanism of action of Interferons (INFs) =
Slows growth of cancer cells and encouraging normal cell behavior (naturally occurring substances in body)
Potential SE of Interferons (IFNs)
- Flu like sx
- Fatigue, Anorexia
- Neuropsychiatric sx
- Electrolyte disturbance
Example of an interleukin
IL-2
Mechanism of action of interleukins =
T cell growth factor
Stimulates growth of natural killer NK cells and cytotoxic T cells to enhance antibody response by binding to receptors on surface of T cells
Potential SE of Interleukins
- Capillary leak syndrome
- Hypotension
- Infusion reactions, rigors, chills, muscle pain, fever, SOB, skin rash/flushing
- Cardiac arrhythmia
- Diarrhea
Cancer Vaccines =
Treat existing* cancers or prevent development of cancer by boosting immune system
Cancer prevention (prophylactic) vaccines (2)
Hepatitis B vaccine -> prevents liver cancer
Human papillomavirus (HPVP -> prevents cervical cancer
Cancer treatment (therapeutic) vaccines (2)
Sipuleucel T -> hormone refractory prostate CA
Talimogene laherparepvec -> metastatic melanoma
Monoclonal antibodies =
Antibodies made in lab that target tumor specific antigens which are proteins that some tumors have
Can make many copies of that antibody hence monoclonal (mAbs)
What does it mean that mAbs are passive?
Do not result in any immunologic memory
3 most common monoclonal antibodies
Rituximab
Trastuzumab
Bevacizumab
How do mAbs work? (3)
1) Flag cancer cells for destruction
2) Block growth signals and receptors
3) Deliver other anticancer agents to site of tumor (when they are bound to other drugs or radiation particles, cancer cell engulfs and digests the mAb, attached chemo/radiation induces cellular death
Where are mAbs derived from before they get to the lab? Whose antibodies?
Human antibodies, animal antibodies, or a combination of the two
Types of mAbs derived from antibodies of
1) mouse
2) mouse and human
3) predominantly human
4) human only
1) Murine
2) Chimeric
3) Humanized
4) Human
Which antigens do these naked MOABS (those that can work alone) target?
1) Alemtuzumab (campath)
2) Trastuzumab (Herceptin)
3) Rituximab
4) Tositumomab
5) Obinutuzimab
6) Imatinib mesylate
1) CD52, CD20
2) HER2
3) CD20
4) CD20
5) CD20
6) Philadelphia chromosome
Mechanism of action of MOABS
Attaches to antigens expressed by specific cancer cells, acting as a marker for body’s immune system to destroy the cells
Antiangiogenic (anti-vascular endothelial growth factor) VEGF naked MOab agents =
Moabs that target the vascular endothelial growth factors that affects and may cause excessive tumor blood vessel growth (angiogenesis)
Examples of Antiangiogenic MOABS
Bevacizumab (Avastin) Pazopanib Sunitinib Sorafenib Axitinib Vandetanib
MoAb that treats CLL
Alemtuzumab (Campath) binds to CD52 antigen
MoAb that treats breast and stomach cancers that have antigen HER2
Trastuzumab (Herceptin)
Conjugated mAbs (2) =
tagged, labeled, loaded antibodies
mAbs combined with chemotherapy or radioactive particles
Radiolabeled antibodies
Chemolabeled antibodies
Ibritumomab tiuxetan (Zevalin) =
Radiolabeled mAb,
Targets CD20 antigen found on B lymphocytes
Tx for refractory or relapsed B Cell NHL
made of rituximab and radioactive substance (Yttrium-90)
Brentuximab Vedotin (Adcetris) =
Chemolabeled mAb
Targets CD30 antigen found on lymphocytes
Tx for refractory Hodgkin Lymphoma
Ado-Tastuzumab emtansine (Kadcyla, TDM-1) =
Chemolabeled mAb
Targets HER2 protein for Metastatic Breast CA
Attached to chemo drug DM1
Bispecific monoclonal antibodies =
Made up of 2 different mAbs -> can attach to 2 different proteins at the same time
Blinatumomab (Blincyto)
Bispecific mAb
Targets CD19 protein found on some leukemia and lymphoma cells and CD3 found on T cells
Cetuximab (Erbitux) =
Chimeric mouse and human antibody
Targets cell protein EGFR (epithelial growth factor receptor)
Adoptive T-Cell Transfer =
CAR-T cell
Collecting T cells which play a primary role in how immune system fights cancer from a patient and engineering them to recognize specific antigens on the surface of cancer cells -> then infusing them back into patient
Two major side effects of CAR-T cell therapy
Cytokine release syndrome
Neuro toxicities
Immune checkpoints =
Traffic lights that prevent over-activation of immune response (attack on healthy cells)
Key component of a healthy immune system
Examples of checkpoints on the surface of immune cells (3)
1) Programmed cell death protein (PD-1)
2) Programmed death ligand (PD-L1)
3) Cytotoxic T lymphocyte-associated protein 4 (CTLA-4)